Table 7

Logistic regression analyses of Crohn's disease patients with work disability as the dependent variable

Variable n UnivariateMultivariate
OR95% CIp ValueOR95% CIp Value
Gender
 Male (ref)811 1
 Female792.221.05 to 4.670.042.411.07 to 5.400.03
Age at diagnosis
 ≤40 years (ref)1241 1
 >40 years362.130.95 to 4.780.071.990.82 to 4.800.13
Education level at diagnosis
Missing=14
 <12 years (ref)871
 >12 years591.270.60 to 2.690.53
Smoking at diagnosis
Missing=2
 Non-smoker (ref)881
 Smoker701.670.81 to 3.450.17
SR or CRP at diagnosis
Missing=5
 ≤30 (ref)491
 >301061.750.76 to 4.050.19
Disease localisation at diagnosis
 L1 or L4 (ref)491
 L2700.630.27 to 1.470.28
 L3410.920.36 to 2.320.85
Disease behaviour at diagnosis
 B1 (ref)971
 B2450.820.36 to 1.90.65
 B3180.820.25 to 2.730.75
Abscess and/or fistula at diagnosis
Missing=10
 Yes (ref)201
 No1301.020.34 to 3.030.97
Steroid treatment at diagnosis
Missing=2
 No (ref)681
 Yes901.400.66 to 2.970.38
Steroid treatment at 1-year follow-up
Missing=4
 No (ref)1021 1
 Yes544.302.00 to 9.28<0.0014.331.96 to 9.59<0.001
Number of relapses during 1st year
Missing=4
 None (ref)751
 1–2691.630.76 to 3.520.21
 >2121.330.32 to 5.540.69
Resection before 1-year follow-up
 No (ref)1301
 Yes300.930.37 to 2.380.88
Mucosal healing at 1-year follow-up
Missing=43
 Yes (ref)561
 No611.200.50 to 2.840.69
ASCA
Missing=13
 Negative (ref)1031
 Positive431.130.50 to 2.580.77
  • No work disability, n=121; work disability, n=39.

  • ASCA, anti-Saccromyces cerevisiae antibodies; Ref, reference category; WD, work disability because IBD (applied for or granted rehabilitation benefits or disability pension).